Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
6Customers
3Debt Items
14Related Chains
Source-Backed Evidence Depth
Natera, Inc. (NTRA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
7High confidence
0.823Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Natera, Inc. Suppliers
No suppliers on recordNatera, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Natera, Inc. Customers
Ticker
Name
Confidence
Evidence
LABORATORY-PARTNERS
LABORATORY-PARTNERS
92%
Further, the Company sells tests to a number of domestic and international laboratory partners and identifies the laboratory partners as customers, provided that there is a test services agreement be…
INSURANCE-CARRIERS
INSURANCE-CARRIERS
90%
The Company enters into contracts with insurance carriers with primarily payment terms related to tests provided to patients who have health insurance coverage.
PATIENTS
PATIENTS
85%
Insurance carriers are considered third-party payers on behalf of the patients, and the patients are considered the customers who receive genetic test services.
Reciprocal relationship from GH graph: Reciprocal relationship from NTRA graph: Reciprocal relationship from GH graph: Reciprocal relationship from NTRA graph: Reciprocal relationship from GH graph: …
BGI-GENOMICS-CO-LTD
BGI-GENOMICS-CO-LTD
62%
4.3 million, respectively, for changes in estimate that increased revenue for tests delivered in prior periods that were fully collected, which increased revenue and decreased net loss by a correspon…
FORESIGHT-DIAGNOSTICS-INC
FORESIGHT-DIAGNOSTICS-INC
62%
. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements. In September 2025, ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Softw…
Natera, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NTRA-DEBT-11392
Warrants outstanding: 0.0978
90%
xbrl warrant detail from xbrl 2025-12-31.
NTRA-DEBT
Debt stack $363.2M
90%
Market cache reports total debt of $363.2M.
NTRA-DEBT-11393
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
Natera, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Natera, Inc..
Natera, Inc. Ownership
Holder
Name
Confidence
Evidence
NTRA-OWNER-JPMORGAN-CHASE-CO
JPMORGAN CHASE & CO
90%
13F overlay lists JPMORGAN CHASE & CO as top holder; 764 tracked holders.
